Anti-coagulant [EPC]

Anti-coagulant [EPC] was reported 3728 times

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ISCHAEMIC MITRAL REGURGITATION 2 0.2500
1 IMAGING PROCEDURE ARTIFACT 3 0.1875
2 ADRENAL THROMBOSIS 3 0.1364
3 ARTERIOVENOUS FISTULA, ACQUIRED 2 0.1333
4 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.1270
5 THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME 5 0.1190
6 OESOPHAGEAL INTRAMURAL HAEMATOMA 8 0.0762
7 LIVER TRANSPLANT FAILURE 3 0.0545
8 HEPARIN-INDUCED THROMBOCYTOPENIA 259 0.0525
9 COAGULATION TIME PROLONGED 77 0.0497
10 HEPARIN RESISTANCE 6 0.0492
11 FIBRIN 2 0.0465
12 COAGULATION TIME ABNORMAL 12 0.0400
13 ILIAC ARTERY OCCLUSION 9 0.0327
14 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0324
15 MEDIASTINAL HAEMORRHAGE 3 0.0309
16 MEDIASTINAL HAEMATOMA 5 0.0301
17 INHIBITING ANTIBODIES 2 0.0286
18 JOINT DEFORMITY 2 0.0267
19 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 10 0.0239
20 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2 0.0238
21 COLONIC HAEMATOMA 2 0.0235
22 VASCULAR STENT THROMBOSIS 47 0.0231
23 CEREBRAL HYPERPERFUSION SYNDROME 2 0.0220
24 CONTRAST ENCEPHALOPATHY 6 0.0217
25 CARDIAC PROCEDURE COMPLICATION 13 0.0214
26 THORACIC HAEMORRHAGE 4 0.0200
27 HAEMORRHAGIC CEREBRAL INFARCTION 14 0.0199
28 VASCULAR STENT OCCLUSION 8 0.0199
29 VASCULAR ACCESS SITE HAEMORRHAGE 3 0.0186
30 MEDICAL DEVICE SITE HAEMORRHAGE 5 0.0176
31 MICROEMBOLISM 2 0.0175
32 INFERIOR VENA CAVAL OCCLUSION 2 0.0174
33 DRY GANGRENE 11 0.0173
34 ACHROMOBACTER INFECTION 2 0.0167
35 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 83 0.0164
36 BURKHOLDERIA TEST POSITIVE 2 0.0161
37 CONGENITAL ARTERIAL MALFORMATION 3 0.0156
38 PRODUCT BARCODE ISSUE 6 0.0155
39 RENAL VEIN THROMBOSIS 10 0.0148
40 MYOCARDIAL STRAIN 2 0.0144
41 HEPATIC ARTERY THROMBOSIS 4 0.0137
42 THROMBOSIS IN DEVICE 44 0.0134
43 PRODUCT PACKAGING DIFFICULT TO OPEN 35 0.0134
44 VASCULAR PSEUDOANEURYSM 23 0.0132
45 CARDIAC VENTRICULAR THROMBOSIS 17 0.0132
46 VENOUS STENOSIS 3 0.0119
47 PUNCTURE SITE HAEMORRHAGE 8 0.0113
48 OPERATIVE HAEMORRHAGE 5 0.0112
49 THERAPEUTIC PRODUCT EFFECT PROLONGED 5 0.0110
50 THROMBOTIC CEREBRAL INFARCTION 4 0.0106
51 ANASTOMOTIC HAEMORRHAGE 2 0.0105
52 HYPOFIBRINOGENAEMIA 10 0.0101
53 ARTERY DISSECTION 4 0.0097
54 HAEMORRHAGIC INFARCTION 5 0.0091
55 COAGULATION TIME SHORTENED 3 0.0090
56 ADRENAL HAEMORRHAGE 5 0.0089
57 FALSE NEGATIVE INVESTIGATION RESULT 6 0.0085
58 TRACHEAL HAEMORRHAGE 3 0.0085
59 VENA CAVA THROMBOSIS 14 0.0084
60 CEREBRAL VENOUS SINUS THROMBOSIS 7 0.0083
61 PHARYNGEAL HAEMORRHAGE 10 0.0081
62 AXILLARY VEIN THROMBOSIS 3 0.0081
63 CATHETER SITE HAEMORRHAGE 20 0.0080
64 PERIPHERAL ARTERY THROMBOSIS 11 0.0078
65 MESENTERIC ARTERY THROMBOSIS 3 0.0078
66 GASTROINTESTINAL LYMPHOMA 2 0.0077
67 HAEMORRHAGIC TRANSFORMATION STROKE 11 0.0073
68 CARDIAC VENTRICULAR DISORDER 3 0.0073
69 ARTERIAL THROMBOSIS LIMB 3 0.0072
70 FISTULA OF SMALL INTESTINE 3 0.0072
71 PELVIC VENOUS THROMBOSIS 10 0.0070
72 AORTIC THROMBOSIS 8 0.0069
73 RETROPERITONEAL HAEMORRHAGE 17 0.0069
74 PERICARDIAL HAEMORRHAGE 15 0.0069
75 CATHETER SITE HAEMATOMA 2 0.0068
76 MESENTERIC PANNICULITIS 2 0.0067
77 POST THROMBOTIC SYNDROME 3 0.0067
78 EMBOLISM ARTERIAL 8 0.0067
79 KOUNIS SYNDROME 15 0.0066
80 CORONARY ARTERY THROMBOSIS 13 0.0064
81 BRONCHIAL HAEMORRHAGE 2 0.0064
82 CHRONIC HEPATITIS B 2 0.0063
83 PERFORATION 5 0.0062
84 RUPTURED CEREBRAL ANEURYSM 4 0.0062
85 INCISION SITE HAEMORRHAGE 5 0.0062
86 ABDOMINAL WALL HAEMATOMA 12 0.0061
87 ARTHRITIS ENTEROPATHIC 2 0.0061
88 ARTERIOVENOUS FISTULA 3 0.0061
89 ISCHAEMIC HEPATITIS 8 0.0058
90 FAT EMBOLISM 2 0.0056
91 GLOMERULONEPHRITIS PROLIFERATIVE 2 0.0055
92 RIGHT VENTRICULAR DYSFUNCTION 6 0.0054
93 LUNG INFECTION PSEUDOMONAL 3 0.0054
94 KLEBSIELLA SEPSIS 6 0.0053
95 HEPATIC INFARCTION 2 0.0053
96 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 3 0.0052
97 CEREBRAL ARTERIOSCLEROSIS 2 0.0052
98 EXTREMITY NECROSIS 9 0.0052
99 HYPOCOAGULABLE STATE 5 0.0051
100 CEREBELLAR STROKE 2 0.0051
101 DEVICE RELATED THROMBOSIS 5 0.0051
102 PERIPHERAL ISCHAEMIA 20 0.0049
103 TERMINAL ILEITIS 3 0.0049
104 HYPERCHLORAEMIA 3 0.0047
105 ANOXIC ENCEPHALOPATHY 3 0.0047
106 PULMONARY ALVEOLAR HAEMORRHAGE 26 0.0046
107 JUGULAR VEIN THROMBOSIS 8 0.0045
108 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
109 FEEDING INTOLERANCE 2 0.0044
110 SUBCLAVIAN VEIN THROMBOSIS 5 0.0044
111 BLOOD FIBRINOGEN DECREASED 5 0.0044
112 ANEURYSM RUPTURED 4 0.0044
113 PANCREATITIS HAEMORRHAGIC 2 0.0043
114 HAEMOTHORAX 12 0.0041
115 EVANS SYNDROME 2 0.0041
116 INTERNATIONAL NORMALISED RATIO INCREASED 115 0.0040
117 MUCOSAL ULCERATION 4 0.0040
118 BRAIN STEM INFARCTION 4 0.0039
119 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 3 0.0039
120 CEREBRAL ARTERY THROMBOSIS 2 0.0039
121 SKIN NECROSIS 20 0.0039
122 PROCEDURAL HAEMORRHAGE 14 0.0036
123 CARDIAC TAMPONADE 17 0.0036
124 ENCEPHALOMALACIA 2 0.0036
125 INTRACRANIAL HAEMATOMA 2 0.0036
126 PNEUMATOSIS INTESTINALIS 10 0.0035
127 SICK SINUS SYNDROME 4 0.0035
128 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
129 MUCOSAL HAEMORRHAGE 4 0.0034
130 SUBARACHNOID HAEMORRHAGE 35 0.0034
131 UPPER AIRWAY OBSTRUCTION 3 0.0034
132 HAEMATOMA MUSCLE 4 0.0033
133 GANGRENE 20 0.0033
134 BLEEDING TIME PROLONGED 4 0.0033
135 COAGULOPATHY 55 0.0033
136 WRONG SCHEDULE 3 0.0031
137 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
138 DISSEMINATED INTRAVASCULAR COAGULATION 44 0.0031
139 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
140 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
141 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
142 POST PROCEDURAL HAEMATOMA 5 0.0030
143 CEREBELLAR INFARCTION 5 0.0030
144 CARDIOGENIC SHOCK 42 0.0029
145 VENOUS THROMBOSIS LIMB 6 0.0029
146 ATRIAL THROMBOSIS 6 0.0029
147 PRODUCT TASTE ABNORMAL 39 0.0029
148 PROTHROMBIN TIME SHORTENED 4 0.0029
149 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
150 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
151 DELAYED GRAFT FUNCTION 2 0.0028
152 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
153 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
154 FINGER AMPUTATION 2 0.0027
155 CORNEAL DEPOSITS 2 0.0027
156 PULMONARY HAEMORRHAGE 21 0.0027
157 ARTERIAL INJURY 2 0.0027
158 CATHETER SITE RELATED REACTION 2 0.0027
159 EMBOLISM VENOUS 8 0.0026
160 ARTERIAL HAEMORRHAGE 3 0.0026
161 HYPERCOAGULATION 5 0.0026
162 PUPILS UNEQUAL 3 0.0026
163 PERIPHERAL EMBOLISM 3 0.0026
164 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
165 ARTERIAL THROMBOSIS 5 0.0026
166 VENTRICULAR FIBRILLATION 28 0.0025
167 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
168 CARDIAC DEATH 3 0.0025
169 HAEMORRHAGE INTRACRANIAL 37 0.0025
170 PRODUCT PACKAGING CONFUSION 6 0.0025
171 CEREBRAL INFARCTION 59 0.0024
172 PROTHROMBIN TIME PROLONGED 14 0.0023
173 SHOCK HAEMORRHAGIC 19 0.0023
174 HEPATIC HAEMORRHAGE 2 0.0023
175 CORONARY ARTERY DISSECTION 2 0.0023
176 PUPIL FIXED 4 0.0023
177 ABDOMINAL LYMPHADENOPATHY 2 0.0023
178 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
179 COMPARTMENT SYNDROME 6 0.0023
180 VENOUS THROMBOSIS 9 0.0023
181 HYPERLEUKOCYTOSIS 2 0.0023
182 PARVOVIRUS B19 INFECTION 2 0.0022
183 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
184 SUBDURAL HAEMORRHAGE 6 0.0022
185 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
186 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
187 BRONCHIAL OBSTRUCTION 3 0.0021
188 PERIPHERAL ARTERY OCCLUSION 3 0.0021
189 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
190 NEUTROPENIC INFECTION 2 0.0021
191 RENAL INFARCT 3 0.0021
192 POST PROCEDURAL HAEMORRHAGE 24 0.0021
193 CROSS SENSITIVITY REACTION 2 0.0021
194 EMBOLISM 17 0.0020
195 GASTROINTESTINAL WALL THICKENING 3 0.0020
196 RIGHT VENTRICULAR FAILURE 14 0.0020
197 EMBOLIC STROKE 7 0.0020
198 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
199 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
200 CATHETER RELATED INFECTION 2 0.0020
201 AUTISM 2 0.0020
202 FIBRIN D DIMER INCREASED 7 0.0020
203 INJECTION SITE NECROSIS 4 0.0020
204 ENDOCARDITIS 10 0.0019
205 ENTEROCOCCAL BACTERAEMIA 2 0.0019
206 HAEMODYNAMIC INSTABILITY 14 0.0018
207 BLADDER DILATATION 2 0.0018
208 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
209 INTESTINAL ISCHAEMIA 10 0.0018
210 ADENOCARCINOMA 4 0.0018
211 CATHETER RELATED COMPLICATION 2 0.0018
212 GAZE PALSY 3 0.0018
213 HAEMORRHAGE 184 0.0018
214 INTERNATIONAL NORMALISED RATIO ABNORMAL 6 0.0017
215 MULTI-ORGAN FAILURE 30 0.0017
216 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
217 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
218 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
219 DIABETES INSIPIDUS 4 0.0017
220 INTRACARDIAC THROMBUS 5 0.0016
221 BRAIN DEATH 5 0.0016
222 AMPUTATION 2 0.0016
223 MECHANICAL VENTILATION 3 0.0016
224 MALLORY-WEISS SYNDROME 2 0.0016
225 APGAR SCORE LOW 2 0.0016
226 IATROGENIC INJURY 2 0.0016
227 PRODUCT LABEL CONFUSION 9 0.0015
228 BICYTOPENIA 3 0.0015
229 INFUSION SITE HAEMORRHAGE 5 0.0015
230 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
231 ANORECTAL DISCOMFORT 8 0.0015
232 EAR HAEMORRHAGE 3 0.0015
233 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
234 GASTRIC HAEMORRHAGE 17 0.0015
235 ECHOCARDIOGRAM ABNORMAL 2 0.0014
236 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
237 ACUTE MYOCARDIAL INFARCTION 42 0.0014
238 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
239 TONGUE DISCOMFORT 6 0.0014
240 CEREBELLAR HAEMORRHAGE 2 0.0014
241 CEREBRAL HAEMORRHAGE 50 0.0014
242 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
243 FOOT AMPUTATION 2 0.0014
244 VENTRICULAR ARRHYTHMIA 5 0.0014
245 HAEMORRHAGIC ANAEMIA 6 0.0014
246 RETROPERITONEAL HAEMATOMA 3 0.0014
247 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
248 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
249 BRAIN HERNIATION 4 0.0013
250 DISTRIBUTIVE SHOCK 3 0.0013
251 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
252 ISCHAEMIA 6 0.0013
253 PROCEDURAL COMPLICATION 10 0.0013
254 DUODENITIS 4 0.0013
255 NEUROLOGICAL DECOMPENSATION 3 0.0013
256 HAEMORRHAGIC STROKE 10 0.0013
257 DEEP VEIN THROMBOSIS 83 0.0013
258 THROMBOSIS 102 0.0013
259 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
260 ANGIOPATHY 7 0.0012
261 LEG AMPUTATION 5 0.0012
262 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
263 PRODUCT USE COMPLAINT 19 0.0012
264 PEPTIC ULCER 4 0.0012
265 HAEMATOMA 31 0.0012
266 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
267 DRUG RESISTANCE 30 0.0012
268 CEREBRAL ISCHAEMIA 6 0.0012
269 GASTROINTESTINAL HAEMORRHAGE 97 0.0012
270 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
271 HAEMATEMESIS 29 0.0011
272 ATELECTASIS 11 0.0011
273 LUNG INFILTRATION 10 0.0011
274 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
275 ABDOMINAL RIGIDITY 3 0.0011
276 HEMIPLEGIA 9 0.0011
277 NECROSIS 6 0.0011
278 INTRACRANIAL PRESSURE INCREASED 6 0.0011
279 ENDOTRACHEAL INTUBATION 3 0.0011
280 ISCHAEMIC STROKE 19 0.0011
281 PULSE ABSENT 5 0.0011
282 DUODENAL ULCER HAEMORRHAGE 3 0.0010
283 ADRENAL DISORDER 2 0.0010
284 COLITIS ISCHAEMIC 7 0.0010
285 COMA SCALE ABNORMAL 3 0.0010
286 VENTRICULAR TACHYCARDIA 17 0.0010
287 BRAIN OEDEMA 13 0.0010
288 HYPERAEMIA 2 0.0010
289 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
290 HYPERCAPNIA 3 0.0010
291 PERICARDIAL EFFUSION 23 0.0010
292 ORGAN FAILURE 4 0.0010
293 RETCHING 21 0.0010
294 EYELID PAIN 2 0.0010
295 DYSAESTHESIA 3 0.0010
296 FIBROSIS 3 0.0010
297 CHANGE OF BOWEL HABIT 2 0.0010
298 CAPILLARY LEAK SYNDROME 2 0.0010
299 INTERNATIONAL NORMALISED RATIO FLUCTUATION 2 0.0010
300 LIVEDO RETICULARIS 2 0.0010
301 MOUTH HAEMORRHAGE 7 0.0010
302 FOREIGN BODY IN THROAT 3 0.0010
303 EAR SWELLING 2 0.0009
304 VENTRICULAR HYPOKINESIA 3 0.0009
305 PROCTALGIA 6 0.0009
306 HYPERPHOSPHATAEMIA 2 0.0009
307 FACIAL PALSY 2 0.0009
308 MELAENA 20 0.0009
309 SUBDURAL HAEMATOMA 13 0.0009
310 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
311 PULMONARY EMBOLISM 85 0.0009
312 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
313 BLOOD LOSS ANAEMIA 2 0.0009
314 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
315 APLASIA PURE RED CELL 3 0.0009
316 PNEUMONIA BACTERIAL 8 0.0009
317 LEFT VENTRICULAR FAILURE 3 0.0009
318 SHOCK 20 0.0009
319 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
320 ELECTROLYTE IMBALANCE 10 0.0009
321 HYPOVOLAEMIA 5 0.0009
322 THROMBOCYTOPENIA 95 0.0008
323 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
324 HAEMORRHAGIC DIATHESIS 3 0.0008
325 HYPOVOLAEMIC SHOCK 4 0.0008
326 INFLAMMATORY MARKER INCREASED 4 0.0008
327 PURPURA 7 0.0008
328 HAEMOPTYSIS 22 0.0008
329 HAEMORRHAGE URINARY TRACT 2 0.0008
330 INCREASED BRONCHIAL SECRETION 2 0.0008
331 POST PROCEDURAL COMPLICATION 15 0.0008
332 ACUTE RESPIRATORY FAILURE 15 0.0008
333 ABNORMAL UTERINE BLEEDING 2 0.0008
334 OESOPHAGEAL DISORDER 3 0.0008
335 DIALYSIS 11 0.0008
336 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
337 MUCORMYCOSIS 2 0.0008
338 CHOKING 15 0.0008
339 PULMONARY HYPERTENSION 16 0.0008
340 HYPOXIA 27 0.0008
341 RESPIRATORY ACIDOSIS 3 0.0008
342 EXFOLIATIVE RASH 2 0.0008
343 CARDIAC FAILURE ACUTE 5 0.0007
344 AREFLEXIA 2 0.0007
345 GASTROINTESTINAL INJURY 2 0.0007
346 CARDIAC ARREST 61 0.0007
347 GASTRIC PERFORATION 2 0.0007
348 INFARCTION 5 0.0007
349 GASTRIC ULCER HAEMORRHAGE 4 0.0007
350 ORAL DISCOMFORT 10 0.0007
351 HAEMODIALYSIS 6 0.0007
352 SEPTIC SHOCK 31 0.0007
353 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
354 NEUTROPENIC SEPSIS 5 0.0007
355 RESPIRATORY FAILURE 51 0.0007
356 PNEUMOTHORAX 11 0.0007
357 FAECES DISCOLOURED 15 0.0007
358 STRESS CARDIOMYOPATHY 4 0.0007
359 RENAL FAILURE ACUTE 29 0.0007
360 HYPERTRIGLYCERIDAEMIA 4 0.0007
361 INFUSION SITE REACTION 2 0.0007
362 IRON DEFICIENCY 3 0.0007
363 ANAL INCONTINENCE 6 0.0007
364 LEUKOCYTOSIS 12 0.0007
365 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
366 PLATELET COUNT ABNORMAL 4 0.0007
367 ABDOMINAL HERNIA 3 0.0007
368 TROPONIN INCREASED 5 0.0007
369 PERIPHERAL COLDNESS 9 0.0007
370 IMMUNE THROMBOCYTOPENIA 3 0.0007
371 UROSEPSIS 6 0.0006
372 RENAL FAILURE CHRONIC 5 0.0006
373 OLIGURIA 4 0.0006
374 HEPATIC FUNCTION ABNORMAL 24 0.0006
375 SKIN TIGHTNESS 3 0.0006
376 DRUG EFFECT INCREASED 2 0.0006
377 THERAPEUTIC RESPONSE CHANGED 4 0.0006
378 TRICUSPID VALVE INCOMPETENCE 5 0.0006
379 ATRIAL FLUTTER 5 0.0006
380 EXPOSURE TO TOXIC AGENT 2 0.0006
381 ENTEROCOCCAL INFECTION 3 0.0006
382 FLUID OVERLOAD 9 0.0006
383 RESPIRATORY DISTRESS 17 0.0006
384 ANGINA UNSTABLE 4 0.0006
385 DECUBITUS ULCER 5 0.0006
386 STAPHYLOCOCCAL SEPSIS 3 0.0006
387 INCORRECT DRUG ADMINISTRATION DURATION 17 0.0006
388 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
389 ANEURYSM 3 0.0006
390 HYPERNATRAEMIA 3 0.0006
391 CEREBRAL HAEMATOMA 2 0.0006
392 ULCER HAEMORRHAGE 4 0.0006
393 HEMIPARESIS 10 0.0006
394 CORONARY ARTERY OCCLUSION 8 0.0006
395 PERIPHERAL VASCULAR DISORDER 3 0.0006
396 UNRESPONSIVE TO STIMULI 15 0.0006
397 COLITIS 22 0.0006
398 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
399 TRANSFUSION 6 0.0006
400 CAROTID ARTERY STENOSIS 2 0.0006
401 RESPIRATORY DEPRESSION 7 0.0006
402 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
403 DEPRESSIVE SYMPTOM 2 0.0006
404 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
405 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
406 STAPHYLOCOCCAL INFECTION 18 0.0005
407 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
408 BLOOD UREA INCREASED 9 0.0005
409 PRODUCT USE ISSUE 101 0.0005
410 RECTAL HAEMORRHAGE 23 0.0005
411 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
412 ACUTE PULMONARY OEDEMA 3 0.0005
413 COLECTOMY 3 0.0005
414 CIRCULATORY COLLAPSE 9 0.0005
415 PARANASAL SINUS DISCOMFORT 2 0.0005
416 ACIDOSIS 4 0.0005
417 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
418 APNOEA 4 0.0005
419 THROMBOTIC MICROANGIOPATHY 5 0.0005
420 CARDIOPULMONARY FAILURE 2 0.0005
421 PLATELET COUNT DECREASED 54 0.0005
422 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
423 BACTERAEMIA 6 0.0005
424 BLOOD ALBUMIN DECREASED 4 0.0005
425 HEPATIC FAILURE 15 0.0005
426 HAEMATURIA 17 0.0005
427 MYASTHENIA GRAVIS 4 0.0005
428 HYPOTHERMIA 5 0.0005
429 PRESYNCOPE 12 0.0005
430 ATRIAL FIBRILLATION 48 0.0005
431 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
432 PARALYSIS 7 0.0005
433 ABNORMAL FAECES 4 0.0005
434 HAEMOGLOBIN DECREASED 50 0.0005
435 ANAPHYLACTOID REACTION 2 0.0005
436 AORTIC DISSECTION 2 0.0005
437 LIVER FUNCTION TEST ABNORMAL 14 0.0005
438 BLOOD BILIRUBIN INCREASED 13 0.0005
439 PRE-EXISTING CONDITION IMPROVED 3 0.0005
440 CARDIO-RESPIRATORY ARREST 20 0.0005
441 LIVE BIRTH 4 0.0005
442 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
443 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
444 AORTIC VALVE INCOMPETENCE 2 0.0005
445 SKIN HYPERPIGMENTATION 4 0.0005
446 PRODUCT PREPARATION ISSUE 3 0.0005
447 SKIN DISCOLOURATION 21 0.0005
448 MELANOCYTIC NAEVUS 2 0.0005
449 SPINAL OSTEOARTHRITIS 4 0.0005
450 PHARYNGEAL OEDEMA 7 0.0005
451 EPISTAXIS 34 0.0005
452 HAEMATOCRIT DECREASED 9 0.0005
453 ABDOMINAL ABSCESS 2 0.0005
454 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
455 EJECTION FRACTION DECREASED 7 0.0004
456 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
457 HAEMOLYTIC ANAEMIA 4 0.0004
458 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
459 MITRAL VALVE INCOMPETENCE 5 0.0004
460 ACUTE HEPATIC FAILURE 6 0.0004
461 ECCHYMOSIS 3 0.0004
462 DISEASE COMPLICATION 2 0.0004
463 PERITONITIS 9 0.0004
464 DRUG INEFFECTIVE 569 0.0004
465 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
466 THERAPEUTIC RESPONSE DECREASED 26 0.0004
467 PLEURAL EFFUSION 26 0.0004
468 DUODENAL ULCER 3 0.0004
469 SINUS TACHYCARDIA 6 0.0004
470 HYPOTENSION 84 0.0004
471 ANHEDONIA 11 0.0004
472 KIDNEY TRANSPLANT REJECTION 2 0.0004
473 APHAGIA 2 0.0004
474 UTERINE LEIOMYOMA 3 0.0004
475 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
476 INCORRECT DOSAGE ADMINISTERED 2 0.0004
477 LIVER INJURY 10 0.0004
478 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
479 HYPERVOLAEMIA 2 0.0004
480 ABDOMINAL TENDERNESS 2 0.0004
481 FLUID INTAKE REDUCED 2 0.0004
482 EOSINOPHILIA 7 0.0004
483 COLD SWEAT 7 0.0004
484 MENTAL STATUS CHANGES 11 0.0004
485 KLEBSIELLA INFECTION 2 0.0004
486 DYSLIPIDAEMIA 2 0.0004
487 THIRST 7 0.0004
488 LIPASE INCREASED 3 0.0004
489 FEMORAL NECK FRACTURE 2 0.0004
490 HAEMOLYSIS 3 0.0004
491 HYPERBILIRUBINAEMIA 4 0.0004
492 FAILURE TO THRIVE 2 0.0004
493 PETECHIAE 4 0.0004
494 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
495 BLOOD LACTIC ACID INCREASED 2 0.0004
496 THROAT IRRITATION 17 0.0004
497 PRODUCT PRESCRIBING ERROR 9 0.0004
498 LOW BIRTH WEIGHT BABY 3 0.0004
499 ULCER 6 0.0004
500 AGRANULOCYTOSIS 7 0.0004
501 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
502 TRANSPLANT REJECTION 3 0.0004
503 FEAR 10 0.0004
504 BLOOD SODIUM DECREASED 7 0.0004
505 ANAL ABSCESS 2 0.0004
506 FREQUENT BOWEL MOVEMENTS 10 0.0004
507 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
508 GASTRIC ULCER 7 0.0004
509 NORMAL NEWBORN 2 0.0004
510 TACHYPNOEA 5 0.0004
511 SEPSIS 41 0.0004
512 PREMATURE BABY 11 0.0004
513 ASPIRATION 4 0.0004
514 ABDOMINAL DISTENSION 38 0.0004
515 CORONARY ARTERY DISEASE 11 0.0004
516 DEAFNESS UNILATERAL 2 0.0004
517 ACUTE CORONARY SYNDROME 3 0.0004
518 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
519 RASH MACULO-PAPULAR 8 0.0004
520 HYPOMAGNESAEMIA 5 0.0004
521 BRADYCARDIA 19 0.0004
522 ATRIAL SEPTAL DEFECT 3 0.0004
523 MALNUTRITION 4 0.0004
524 RENAL IMPAIRMENT 30 0.0004
525 ABDOMINAL PAIN LOWER 9 0.0004
526 INFUSION SITE ERYTHEMA 3 0.0004
527 DEVICE OCCLUSION 5 0.0004
528 RENAL FAILURE 47 0.0004
529 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
530 ANURIA 3 0.0003
531 HERPES VIRUS INFECTION 2 0.0003
532 BLOOD URIC ACID INCREASED 2 0.0003
533 BLOOD PRESSURE DECREASED 23 0.0003
534 HYPERVENTILATION 2 0.0003
535 METABOLIC DISORDER 2 0.0003
536 ANAPHYLACTIC REACTION 19 0.0003
537 URINE OUTPUT DECREASED 3 0.0003
538 LACTIC ACIDOSIS 11 0.0003
539 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
540 RESPIRATORY RATE INCREASED 3 0.0003
541 CARDIAC FAILURE 27 0.0003
542 RHABDOMYOLYSIS 14 0.0003
543 PULMONARY OEDEMA 15 0.0003
544 ADRENAL INSUFFICIENCY 4 0.0003
545 TREATMENT NONCOMPLIANCE 18 0.0003
546 DEVICE FAILURE 5 0.0003
547 DISCOMFORT 20 0.0003
548 HAEMATOCHEZIA 18 0.0003
549 DRUG ADMINISTRATION ERROR 10 0.0003
550 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
551 LARYNGEAL OEDEMA 2 0.0003
552 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
553 FEELING COLD 9 0.0003
554 INFUSION SITE EXTRAVASATION 2 0.0003
555 DEFORMITY 3 0.0003
556 CYANOSIS 5 0.0003
557 DELIRIUM 11 0.0003
558 ANAEMIA 60 0.0003
559 FOREIGN BODY SENSATION IN EYES 2 0.0003
560 INJURY 22 0.0003
561 OFF LABEL USE 274 0.0003
562 ENTERITIS 2 0.0003
563 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
564 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
565 ANAPHYLACTIC SHOCK 8 0.0003
566 HEART RATE IRREGULAR 7 0.0003
567 RENAL TUBULAR NECROSIS 3 0.0003
568 HEPATOMEGALY 3 0.0003
569 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
570 ADVERSE REACTION 4 0.0003
571 RESPIRATORY DISORDER 9 0.0003
572 LIP SWELLING 10 0.0003
573 OVARIAN CYST 3 0.0003
574 BRAIN INJURY 3 0.0003
575 VOMITING 140 0.0003
576 THROAT TIGHTNESS 8 0.0003
577 DRUG TOXICITY 4 0.0003
578 INCORRECT DOSE ADMINISTERED 67 0.0003
579 LIVER DISORDER 13 0.0003
580 NEUTROPHIL COUNT INCREASED 3 0.0003
581 BLOOD CREATININE INCREASED 19 0.0003
582 VENTRICULAR EXTRASYSTOLES 3 0.0003
583 TENDERNESS 3 0.0003
584 HYPERKALAEMIA 10 0.0003
585 PAPULE 2 0.0003
586 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
587 LYMPHOCYTE COUNT DECREASED 5 0.0003
588 HYPOKALAEMIA 13 0.0003
589 PNEUMONIA ASPIRATION 7 0.0003
590 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
591 IMPAIRED QUALITY OF LIFE 4 0.0003
592 SKIN LACERATION 3 0.0003
593 FAECES SOFT 2 0.0003
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
595 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
596 HYPOPHOSPHATAEMIA 2 0.0003
597 MEDICAL DEVICE COMPLICATION 2 0.0003
598 MEDICATION ERROR 15 0.0003
599 DRUG DEPENDENCE 43 0.0003
600 BLISTER 15 0.0003
601 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
602 TREATMENT FAILURE 22 0.0003
603 APHASIA 8 0.0003
604 INTERNAL HAEMORRHAGE 3 0.0003
605 CARDIAC FAILURE CONGESTIVE 21 0.0003
606 ACUTE KIDNEY INJURY 40 0.0003
607 BOWEL MOVEMENT IRREGULARITY 2 0.0003
608 MUSCLE TWITCHING 6 0.0003
609 ATRIOVENTRICULAR BLOCK 2 0.0003
610 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
611 VASCULITIS 3 0.0003
612 HYPOALBUMINAEMIA 2 0.0003
613 GASTROINTESTINAL INFLAMMATION 2 0.0003
614 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
615 DYSPEPSIA 25 0.0003
616 COVID-19 PNEUMONIA 3 0.0003
617 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
618 LOSS OF CONSCIOUSNESS 32 0.0002
619 BLOOD DISORDER 2 0.0002
620 OXYGEN SATURATION DECREASED 14 0.0002
621 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
622 FRUSTRATION TOLERANCE DECREASED 2 0.0002
623 MUSCLE DISORDER 2 0.0002
624 SMALL INTESTINAL OBSTRUCTION 3 0.0002
625 EYE DISORDER 8 0.0002
626 GENERALISED OEDEMA 3 0.0002
627 MYOCARDIAL INFARCTION 42 0.0002
628 INJECTION SITE DISCOLOURATION 3 0.0002
629 DYSARTHRIA 9 0.0002
630 ASCITES 7 0.0002
631 UNEVALUABLE EVENT 18 0.0002
632 ABDOMINAL PAIN 55 0.0002
633 TACHYCARDIA 21 0.0002
634 GASTROINTESTINAL DISORDER 21 0.0002
635 SCAR 4 0.0002
636 DEHYDRATION 31 0.0002
637 SKIN ULCER 6 0.0002
638 DISEASE RECURRENCE 11 0.0002
639 HYSTERECTOMY 2 0.0002
640 HYPONATRAEMIA 13 0.0002
641 SWELLING FACE 15 0.0002
642 BLOOD CALCIUM INCREASED 2 0.0002
643 DRUG INTERACTION 36 0.0002
644 CHEST PAIN 42 0.0002
645 JOINT RANGE OF MOTION DECREASED 3 0.0002
646 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
647 OROPHARYNGEAL DISCOMFORT 2 0.0002
648 PALLOR 6 0.0002
649 IMPAIRED GASTRIC EMPTYING 3 0.0002
650 GINGIVAL BLEEDING 3 0.0002
651 PATHOGEN RESISTANCE 2 0.0002
652 END STAGE RENAL DISEASE 4 0.0002
653 MOVEMENT DISORDER 7 0.0002
654 NERVE COMPRESSION 2 0.0002
655 POLLAKIURIA 9 0.0002
656 EYE SWELLING 8 0.0002
657 MASS 3 0.0002
658 NEPHROPATHY 2 0.0002
659 FLANK PAIN 2 0.0002
660 OSTEONECROSIS 7 0.0002
661 PHOTOPHOBIA 4 0.0002
662 FLATULENCE 12 0.0002
663 HYPOCALCAEMIA 4 0.0002
664 ARRHYTHMIA 10 0.0002
665 BLOOD URINE PRESENT 4 0.0002
666 URTICARIA 35 0.0002
667 PULMONARY FIBROSIS 4 0.0002
668 PRODUCT SUBSTITUTION ISSUE 12 0.0002
669 PARAESTHESIA ORAL 3 0.0002
670 VAGINAL HAEMORRHAGE 9 0.0002
671 HYPOKINESIA 3 0.0002
672 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
673 NAUSEA 162 0.0002
674 ABDOMINAL PAIN UPPER 42 0.0002
675 GASTRIC DISORDER 7 0.0002
676 ENCEPHALOPATHY 5 0.0002
677 DISABILITY 4 0.0002
678 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
679 THERAPY NON-RESPONDER 9 0.0002
680 HYPOAESTHESIA ORAL 3 0.0002
681 ECONOMIC PROBLEM 3 0.0002
682 NECK PAIN 11 0.0002
683 BLOOD PRESSURE INCREASED 30 0.0002
684 RENAL DISORDER 9 0.0002
685 EXPOSURE DURING PREGNANCY 12 0.0002
686 THERAPY PARTIAL RESPONDER 3 0.0002
687 SWOLLEN TONGUE 6 0.0002
688 UNDERDOSE 14 0.0002
689 RESTLESSNESS 7 0.0002
690 GASTRITIS 5 0.0002
691 INCONTINENCE 2 0.0002
692 COMA 9 0.0002
693 CEREBROVASCULAR ACCIDENT 32 0.0002
694 PNEUMONIA 61 0.0002
695 CHILLS 22 0.0002
696 METABOLIC ACIDOSIS 6 0.0002
697 CHEST DISCOMFORT 19 0.0002
698 DECREASED ACTIVITY 2 0.0002
699 MUSCLE TIGHTNESS 3 0.0002
700 OEDEMA 10 0.0002
701 LUNG DISORDER 9 0.0002
702 OESOPHAGITIS 2 0.0002
703 DRUG LEVEL INCREASED 3 0.0002
704 CONDITION AGGRAVATED 55 0.0002
705 EXPIRED PRODUCT ADMINISTERED 6 0.0002
706 SYNCOPE 18 0.0002
707 NEPHROPATHY TOXIC 2 0.0002
708 INTESTINAL PERFORATION 2 0.0002
709 BLOOD CALCIUM DECREASED 2 0.0002
710 CHROMATURIA 4 0.0002
711 DISORIENTATION 7 0.0002
712 MYOCARDIAL ISCHAEMIA 2 0.0002
713 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
714 RED BLOOD CELL COUNT DECREASED 5 0.0002
715 CONVULSION 10 0.0002
716 ILLNESS 18 0.0002
717 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
718 EYELID OEDEMA 2 0.0002
719 SPEECH DISORDER 9 0.0002
720 PRODUCT STORAGE ERROR 15 0.0002
721 DYSSTASIA 5 0.0002
722 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
723 LYMPHADENOPATHY 6 0.0002
724 HEAD DISCOMFORT 3 0.0002
725 DYSPHAGIA 16 0.0002
726 RENAL INJURY 5 0.0002
727 MUSCLE RIGIDITY 2 0.0002
728 HYPERSENSITIVITY 31 0.0002
729 DIARRHOEA 107 0.0002
730 OSTEOMYELITIS 3 0.0002
731 EPILEPSY 5 0.0002
732 CONJUNCTIVITIS 3 0.0002
733 HEPATIC ENZYME INCREASED 11 0.0002
734 HEPATIC STEATOSIS 3 0.0002
735 BACTERIAL INFECTION 3 0.0002
736 MIDDLE INSOMNIA 3 0.0002
737 LEUKOPENIA 8 0.0002
738 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
739 PRODUCT COMPLAINT 4 0.0002
740 CARDIOVASCULAR DISORDER 4 0.0002
741 FEELING JITTERY 3 0.0002
742 CHOLESTASIS 3 0.0002
743 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
744 HYPERHIDROSIS 20 0.0002
745 PRESCRIBED OVERDOSE 3 0.0002
746 PRODUCT QUALITY ISSUE 21 0.0002
747 HIATUS HERNIA 2 0.0002
748 DYSPHONIA 9 0.0002
749 AMNESIA 10 0.0002
750 NODULE 2 0.0002
751 DEAFNESS 4 0.0002
752 JOINT STIFFNESS 4 0.0002
753 BEDRIDDEN 2 0.0002
754 IMMUNE SYSTEM DISORDER 2 0.0002
755 HEART RATE INCREASED 15 0.0002
756 URINARY RETENTION 5 0.0001
757 AGITATION 11 0.0001
758 GAIT INABILITY 5 0.0001
759 SWELLING 14 0.0001
760 PRODUCT ADMINISTRATION ERROR 3 0.0001
761 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
762 TASTE DISORDER 3 0.0001
763 BODY TEMPERATURE INCREASED 3 0.0001
764 HEADACHE 92 0.0001
765 SKIN LESION 4 0.0001
766 RESPIRATORY ARREST 4 0.0001
767 CHRONIC KIDNEY DISEASE 11 0.0001
768 OVERDOSE 31 0.0001
769 DYSPNOEA 81 0.0001
770 HALLUCINATION, VISUAL 3 0.0001
771 BLINDNESS UNILATERAL 2 0.0001
772 HEPATOCELLULAR INJURY 2 0.0001
773 EATING DISORDER 3 0.0001
774 JOINT INJURY 3 0.0001
775 BRONCHOSPASM 2 0.0001
776 ANGINA PECTORIS 4 0.0001
777 CELLULITIS 7 0.0001
778 TREMOR 23 0.0001
779 SEIZURE 16 0.0001
780 C-REACTIVE PROTEIN INCREASED 5 0.0001
781 ANXIETY 39 0.0001
782 ACCIDENTAL OVERDOSE 5 0.0001
783 MUSCLE SPASMS 25 0.0001
784 STEVENS-JOHNSON SYNDROME 3 0.0001
785 TRANSAMINASES INCREASED 3 0.0001
786 URINARY TRACT INFECTION 23 0.0001
787 COLON CANCER 2 0.0001
788 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
789 PANCREATITIS ACUTE 3 0.0001
790 BLOOD POTASSIUM DECREASED 4 0.0001
791 INTESTINAL OBSTRUCTION 5 0.0001
792 HYPERTENSION 28 0.0001
793 OSTEOPENIA 2 0.0001
794 ERYTHEMA 27 0.0001
795 OEDEMA PERIPHERAL 16 0.0001
796 ABDOMINAL DISCOMFORT 22 0.0001
797 DRUG DISPENSING ERROR 2 0.0001
798 NEPHROLITHIASIS 6 0.0001
799 TINNITUS 6 0.0001
800 DEVICE RELATED INFECTION 2 0.0001
801 LUNG INFECTION 2 0.0001
802 CONSTIPATION 28 0.0001
803 PALPITATIONS 15 0.0001
804 DRUG-INDUCED LIVER INJURY 4 0.0001
805 DIZZINESS 63 0.0001
806 HALLUCINATION, AUDITORY 2 0.0001
807 INTENTIONAL PRODUCT MISUSE 11 0.0001
808 CYSTITIS 4 0.0001
809 ABSCESS 2 0.0001
810 BLOOD PRESSURE FLUCTUATION 3 0.0001
811 MENTAL IMPAIRMENT 3 0.0001
812 EXTRA DOSE ADMINISTERED 5 0.0001
813 MUSCULAR WEAKNESS 14 0.0001
814 BLOOD POTASSIUM INCREASED 2 0.0001
815 BLINDNESS 5 0.0001
816 CHOLELITHIASIS 4 0.0001
817 IMPAIRED HEALING 4 0.0001
818 FEBRILE NEUTROPENIA 8 0.0001
819 VIRAL INFECTION 4 0.0001
820 PAIN IN EXTREMITY 35 0.0001
821 CANDIDA INFECTION 2 0.0001
822 DISEASE PROGRESSION 14 0.0001
823 DIABETES MELLITUS 9 0.0001
824 CONFUSIONAL STATE 19 0.0001
825 HYPOPHAGIA 3 0.0001
826 MUSCULOSKELETAL DISCOMFORT 2 0.0001
827 PYREXIA 40 0.0001
828 DIPLOPIA 3 0.0001
829 ORTHOSTATIC HYPOTENSION 2 0.0001
830 LOCAL SWELLING 2 0.0001
831 MUSCULOSKELETAL PAIN 6 0.0001
832 BURNING SENSATION 8 0.0001
833 HEART RATE DECREASED 4 0.0001
834 ANGIOEDEMA 5 0.0001
835 GALLBLADDER DISORDER 2 0.0001
836 MALAISE 49 0.0001
837 DRUG EFFECT DECREASED 6 0.0001
838 GASTROENTERITIS VIRAL 2 0.0001
839 LIMB INJURY 3 0.0001
840 DRUG EFFECT INCOMPLETE 4 0.0001
841 BONE DISORDER 2 0.0001
842 PANIC ATTACK 4 0.0001
843 PROCEDURAL PAIN 3 0.0001
844 BRONCHITIS 8 0.0001
845 PARAESTHESIA 17 0.0001
846 PAIN 65 0.0001
847 MUSCULOSKELETAL DISORDER 2 0.0001
848 NO ADVERSE EVENT 19 0.0001
849 RASH ERYTHEMATOUS 5 0.0001
850 LOWER LIMB FRACTURE 2 0.0001
851 CONTUSION 10 0.0001
852 HERNIA 2 0.0001
853 HAEMORRHOIDS 2 0.0001
854 LABORATORY TEST ABNORMAL 3 0.0001
855 PSYCHOTIC DISORDER 3 0.0001
856 INSOMNIA 27 0.0001
857 WHEEZING 6 0.0001
858 RASH 44 0.0001
859 HYPOAESTHESIA 15 0.0001
860 FEELING ABNORMAL 24 0.0001
861 FULL BLOOD COUNT DECREASED 2 0.0001
862 BONE MARROW FAILURE 2 0.0001
863 CARDIAC DISORDER 9 0.0001
864 NERVOUSNESS 5 0.0001
865 INTENTIONAL DRUG MISUSE 2 0.0001
866 NEUTROPENIA 13 0.0001
867 BLOOD GLUCOSE INCREASED 18 0.0001
868 DERMATITIS 2 0.0001
869 SKIN EXFOLIATION 8 0.0001
870 MIGRAINE 9 0.0001
871 DYSGEUSIA 7 0.0001
872 HYPOTHYROIDISM 3 0.0001
873 IMPAIRED WORK ABILITY 2 0.0001
874 HALLUCINATION 7 0.0001
875 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
876 MENTAL DISORDER 4 0.0001
877 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
878 EMOTIONAL DISTRESS 11 0.0001
879 INFUSION RELATED REACTION 6 0.0001
880 SKIN DISORDER 3 0.0001
881 HEPATOTOXICITY 2 0.0001
882 COLITIS ULCERATIVE 4 0.0001
883 ORAL PAIN 2 0.0001
884 DEATH 76 0.0001
885 DECREASED APPETITE 20 0.0001
886 COGNITIVE DISORDER 4 0.0001
887 SLEEP DISORDER 6 0.0001
888 PERIPHERAL SWELLING 13 0.0001
889 OCULAR HYPERAEMIA 4 0.0001
890 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
891 INTERSTITIAL LUNG DISEASE 4 0.0001
892 HYPOGLYCAEMIA 4 0.0001
893 HYPERGLYCAEMIA 3 0.0001
894 NEURALGIA 2 0.0001
895 VERTIGO 5 0.0001
896 BACK PAIN 19 0.0001
897 FEELING HOT 5 0.0001
898 PRURITUS 31 0.0001
899 VISION BLURRED 11 0.0001
900 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
901 ASTHMA 9 0.0001
902 ADVERSE DRUG REACTION 7 0.0001
903 INFLAMMATION 4 0.0001
904 ASTHENIA 29 0.0001
905 MUCOSAL INFLAMMATION 2 0.0001
906 DERMATITIS ATOPIC 4 0.0001
907 OROPHARYNGEAL PAIN 7 0.0001
908 COUGH 21 0.0001
909 JAUNDICE 2 0.0001
910 PAIN OF SKIN 2 0.0001
911 GAIT DISTURBANCE 14 0.0001
912 DEPENDENCE 4 0.0001
913 DRUG INTOLERANCE 7 0.0001
914 PANCYTOPENIA 4 0.0001
915 DEMENTIA 2 0.0001
916 WEIGHT INCREASED 16 0.0001
917 DEVICE MALFUNCTION 5 0.0001
918 LETHARGY 4 0.0001
919 FLUSHING 7 0.0001
920 BONE PAIN 4 0.0001
921 NASAL CONGESTION 4 0.0001
922 TOXICITY TO VARIOUS AGENTS 11 0.0001
923 EMOTIONAL DISORDER 2 0.0001
924 LIMB DISCOMFORT 2 0.0001
925 FEMUR FRACTURE 2 0.0001
926 SOMNOLENCE 13 0.0001
927 NERVOUS SYSTEM DISORDER 2 0.0001
928 HEAD INJURY 2 0.0001
929 FALL 21 0.0001
930 PRODUCTIVE COUGH 3 0.0001
931 WEIGHT DECREASED 17 0.0001
932 FLUID RETENTION 3 0.0001
933 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
934 DEVICE USE ERROR 2 0.0001
935 NEOPLASM PROGRESSION 2 0.0001
936 ECZEMA 3 0.0001
937 MUSCULOSKELETAL STIFFNESS 5 0.0001
938 VISUAL IMPAIRMENT 7 0.0001
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
940 ALOPECIA 11 0.0001
941 THERAPY INTERRUPTED 4 0.0001
942 MOBILITY DECREASED 4 0.0001
943 RASH PRURITIC 3 0.0001
944 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
945 ARTHRALGIA 23 0.0001
946 INFECTION 8 0.0001
947 DYSURIA 2 0.0001
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
949 EYE PAIN 3 0.0001
950 DYSPNOEA EXERTIONAL 2 0.0001
951 HOT FLUSH 4 0.0001
952 DEPRESSION 12 0.0001
953 FATIGUE 41 0.0001
954 HERPES ZOSTER 3 0.0001
955 HOSPITALISATION 8 0.0001
956 IRRITABILITY 3 0.0000
957 STOMATITIS 3 0.0000
958 ILL-DEFINED DISORDER 3 0.0000
959 LUNG NEOPLASM MALIGNANT 2 0.0000
960 OSTEOPOROSIS 2 0.0000
961 RHINORRHOEA 3 0.0000
962 BALANCE DISORDER 4 0.0000
963 COVID-19 8 0.0000
964 SUICIDAL IDEATION 4 0.0000
965 NASOPHARYNGITIS 8 0.0000
966 NEUROPATHY PERIPHERAL 4 0.0000
967 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
968 JOINT SWELLING 5 0.0000
969 INJECTION SITE SWELLING 3 0.0000
970 SINUSITIS 4 0.0000
971 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
972 PANCREATITIS 2 0.0000
973 INJECTION SITE HAEMORRHAGE 3 0.0000
974 DRY SKIN 5 0.0000
975 PROSTATE CANCER 3 0.0000
976 INFLUENZA 4 0.0000
977 MYALGIA 6 0.0000
978 PRODUCT DOSE OMISSION ISSUE 10 0.0000
979 BLADDER CANCER 2 0.0000
980 CATARACT 2 0.0000
981 ADVERSE EVENT 3 0.0000
982 PSORIASIS 4 0.0000
983 NEOPLASM MALIGNANT 2 0.0000
984 MEMORY IMPAIRMENT 4 0.0000
985 INJECTION SITE PAIN 8 0.0000
986 DRUG DOSE OMISSION BY DEVICE 2 0.0000
987 INJECTION SITE BRUISING 2 0.0000
988 DRY MOUTH 2 0.0000
989 DRUG DOSE OMISSION 4 0.0000
990 INJECTION SITE ERYTHEMA 3 0.0000
991 DRUG ABUSE 2 0.0000
992 DRUG WITHDRAWAL SYNDROME 2 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000